Tarsus Pharmaceuticals (TARS) Non-Current Debt (2022 - 2026)
Tarsus Pharmaceuticals' Non-Current Debt was $72.76 million in Q2 2026, up 0.9% from $72.13 million a year earlier and up 0.2% from the prior quarter.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) Non-Current Debt (2022 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Debt at Tarsus Pharmaceuticals came in at $72.44 million, up 0.8% from FY2024.
- Non-Current Debt has now increased for three consecutive years, with a three-year compound annual growth rate of 55.0% (FY2022 to FY2025).
- In earlier years, Non-Current Debt was $71.85 million in FY2024 (+140.9%), $29.82 million in FY2023 (+53.4%) and $19.43 million in FY2022.
- The Q2 2026 figure marks the highest quarterly Non-Current Debt in data going back to Q1 2022.
- Compared with a year earlier, Non-Current Debt has increased for 14 straight quarters, with growth averaging 53.4% over the last eight quarters.
- Over the past five years, the year-over-year growth in Non-Current Debt ranged from 0.8% (Q2 2025) to 190.9% (Q2 2024).
- Per Business Quant data, TARS's Non-Current Debt in the three quarters before Q2 2026 was $72.6 million (Q1 2026), $72.44 million (Q4 2025) and $72.28 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -108.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 51.86 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 23.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 60.50 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Tarsus Pharmaceuticals | 3.32 Bn | 2.27 Bn | 161.80 Mn | 72.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 72.76 Mn |
| Mar 31, 2026 | 72.60 Mn |
| Dec 31, 2025 | 72.44 Mn |
| Sep 30, 2025 | 72.28 Mn |
| Jun 30, 2025 | 72.13 Mn |
| Mar 31, 2025 | 71.98 Mn |
| Dec 31, 2024 | 71.85 Mn |
| Sep 30, 2024 | 71.71 Mn |
| Jun 30, 2024 | 71.58 Mn |
| Mar 31, 2024 | 29.93 Mn |
| Dec 31, 2023 | 29.82 Mn |
| Sep 30, 2023 | 29.71 Mn |
| Jun 30, 2023 | 24.61 Mn |
| Mar 31, 2023 | 24.52 Mn |
| Dec 31, 2022 | 19.43 Mn |
| Sep 30, 2022 | 19.36 Mn |
| Jun 30, 2022 | 19.26 Mn |
| Mar 31, 2022 | 19.18 Mn |
API Access
Tarsus Pharmaceuticals Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=TARS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();